Tapinarof

(Vtama®)

Vtama®

Drug updated on 11/15/2023

Dosage FormCream (topical; 1%)
Drug ClassAryl hydrocarbon receptor agonists
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Indicated for the topical treatment of plaque psoriasis in adults.

Product Monograph / Prescribing Information

Document TitleYearSource
Vtama (tapinarof) Prescribing information. 2022Dermavant Sciences Inc., Long Beach, CA

Systematic Reviews / Meta-Analyses

Document TitleYearSource
Topical Agents Currently in Phase II or Phase III Trials for Atopic Dermatitis. 2020Journal of Drugs in Dermatology